Literature DB >> 20063303

Power calculations for multicenter imaging studies controlled by the false discovery rate.

John Suckling1, Anna Barnes, Dominic Job, David Brenan, Katherine Lymer, Paola Dazzan, Tiago Reis Marques, Clare MacKay, Shane McKie, Steve R Williams, Steven C R Williams, Stephen Lawrie, Bill Deakin.   

Abstract

Magnetic resonance imaging (MRI) is widely used in brain imaging research (neuroimaging) to explore structural and functional changes across dispersed neural networks visible only via multisubject experiments. Multicenter investigations are an effective way to increase recruitment rates. This article describes image-based power calculations for a two-group, cross-sectional design specified by the mean effect size and its standard error, sample size, false discovery rate (FDR), and size of the network (i.e., proportion of image locations) that truly demonstrates an effect. Minimum sample size (for fixed effect size) and the minimum effect size (for fixed sample size) are calculated by specifying the acceptable power threshold. Within-center variance was estimated in five participating centers by repeat MRI scanning of 12 healthy participants from whom distributions of gray matter were estimated. The effect on outcome measures when varying FDR and the proportion of true positives is presented. Their spatial patterns reflect within-center variance, which is consistent across centers. Sample sizes 3-6 times larger are needed when detecting effects in subcortical regions compared to the neocortex. Hypothesized multicenter studies of patients with first episode psychosis and control participants were simulated with varying proportions of the cohort recruited at each center. There is little penalty to sample size for recruitment at five centers compared to the center with the lowest variance alone. At 80% power 80 participants per group are required to observe differences in gray matter in high variance regions. 2010 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2010        PMID: 20063303      PMCID: PMC6870605          DOI: 10.1002/hbm.20927

Source DB:  PubMed          Journal:  Hum Brain Mapp        ISSN: 1065-9471            Impact factor:   5.038


  31 in total

1.  Thresholding of statistical maps in functional neuroimaging using the false discovery rate.

Authors:  Christopher R Genovese; Nicole A Lazar; Thomas Nichols
Journal:  Neuroimage       Date:  2002-04       Impact factor: 6.556

2.  A note on using permutation-based false discovery rate estimates to compare different analysis methods for microarray data.

Authors:  Yang Xie; Wei Pan; Arkady B Khodursky
Journal:  Bioinformatics       Date:  2005-09-27       Impact factor: 6.937

3.  Reducing interscanner variability of activation in a multicenter fMRI study: controlling for signal-to-fluctuation-noise-ratio (SFNR) differences.

Authors:  Lee Friedman; Gary H Glover
Journal:  Neuroimage       Date:  2006-09-06       Impact factor: 6.556

4.  Power calculation for group fMRI studies accounting for arbitrary design and temporal autocorrelation.

Authors:  Jeanette A Mumford; Thomas E Nichols
Journal:  Neuroimage       Date:  2007-08-19       Impact factor: 6.556

5.  Power and sample size calculation for neuroimaging studies by non-central random field theory.

Authors:  Satoru Hayasaka; Ann M Peiffer; Christina E Hugenschmidt; Paul J Laurienti
Journal:  Neuroimage       Date:  2007-06-18       Impact factor: 6.556

Review 6.  What we can do and what we cannot do with fMRI.

Authors:  Nikos K Logothetis
Journal:  Nature       Date:  2008-06-12       Impact factor: 49.962

7.  Mapping voxel-based statistical power on parametric images.

Authors:  J D Van Horn; T M Ellmore; G Esposito; K F Berman
Journal:  Neuroimage       Date:  1998-02       Impact factor: 6.556

8.  Diurnal cortisol amplitude and fronto-limbic activity in response to stressful stimuli.

Authors:  Amy C Cunningham-Bussel; James C Root; Tracy Butler; Oliver Tuescher; Hong Pan; Jane Epstein; Daniel S Weisholtz; Michelle Pavony; Michael E Silverman; Martin S Goldstein; Margaret Altemus; Marylene Cloitre; Joseph Ledoux; Bruce McEwen; Emily Stern; David Silbersweig
Journal:  Psychoneuroendocrinology       Date:  2009-01-09       Impact factor: 4.905

Review 9.  Fast robust automated brain extraction.

Authors:  Stephen M Smith
Journal:  Hum Brain Mapp       Date:  2002-11       Impact factor: 5.038

10.  Components of variance in a multicentre functional MRI study and implications for calculation of statistical power.

Authors:  John Suckling; David Ohlssen; Christopher Andrew; Glyn Johnson; Steven C R Williams; Martin Graves; Chi-Hua Chen; David Spiegelhalter; Ed Bullmore
Journal:  Hum Brain Mapp       Date:  2008-10       Impact factor: 5.038

View more
  23 in total

1.  Effects of combining field strengths on auditory functional MRI group analysis: 1.5T and 3T.

Authors:  Kihwan Han; Thomas M Talavage
Journal:  J Magn Reson Imaging       Date:  2011-09-29       Impact factor: 4.813

2.  Volumetric abnormalities predating the onset of schizophrenia and affective psychoses: an MRI study in subjects at ultrahigh risk of psychosis.

Authors:  Paola Dazzan; Bridget Soulsby; Andrea Mechelli; Stephen J Wood; Dennis Velakoulis; Lisa J Phillips; Alison R Yung; Xavier Chitnis; Ashleigh Lin; Robin M Murray; Patrick D McGorry; Philip K McGuire; Christos Pantelis
Journal:  Schizophr Bull       Date:  2011-04-25       Impact factor: 9.306

Review 3.  Using brain imaging measures in studies of procognitive pharmacologic agents in schizophrenia: psychometric and quality assurance considerations.

Authors:  Deanna M Barch; Daniel H Mathalon
Journal:  Biol Psychiatry       Date:  2011-02-21       Impact factor: 13.382

4.  The Neuro/PsyGRID calibration experiment: identifying sources of variance and bias in multicenter MRI studies.

Authors:  John Suckling; Anna Barnes; Dominic Job; David Brennan; Katherine Lymer; Paola Dazzan; Tiago Reis Marques; Clare MacKay; Shane McKie; Steve R Williams; Steven C R Williams; Bill Deakin; Stephen Lawrie
Journal:  Hum Brain Mapp       Date:  2011-03-21       Impact factor: 5.038

5.  Permutation and parametric tests for effect sizes in voxel-based morphometry of gray matter volume in brain structural MRI.

Authors:  David A Dickie; Shadia Mikhael; Dominic E Job; Joanna M Wardlaw; David H Laidlaw; Mark E Bastin
Journal:  Magn Reson Imaging       Date:  2015-08-05       Impact factor: 2.546

6.  Statistical harmonization corrects site effects in functional connectivity measurements from multi-site fMRI data.

Authors:  Meichen Yu; Kristin A Linn; Philip A Cook; Mary L Phillips; Melvin McInnis; Maurizio Fava; Madhukar H Trivedi; Myrna M Weissman; Russell T Shinohara; Yvette I Sheline
Journal:  Hum Brain Mapp       Date:  2018-07-01       Impact factor: 5.038

7.  Functional Striatal Abnormalities: A Distinct Brain Signature of Schizophrenia.

Authors:  Sugai Liang; Tao Li
Journal:  Neurosci Bull       Date:  2020-10-23       Impact factor: 5.203

8.  Assessment of the impact of the scanner-related factors on brain morphometry analysis with Brainvisa.

Authors:  Mahsa Shokouhi; Anna Barnes; John Suckling; Thomas Wj Moorhead; David Brennan; Dominic Job; Katherine Lymer; Paola Dazzan; Tiago Reis Marques; Clare Mackay; Shane McKie; Steven Cr Williams; Stephen M Lawrie; Bill Deakin; Steve R Williams; Barrie Condon
Journal:  BMC Med Imaging       Date:  2011-12-21       Impact factor: 1.930

9.  An iterative jackknife approach for assessing reliability and power of FMRI group analyses.

Authors:  Marko Wilke
Journal:  PLoS One       Date:  2012-04-17       Impact factor: 3.240

10.  A multi-scanner study of subcortical brain volume abnormalities in schizophrenia.

Authors:  Theo G M van Erp; Douglas N Greve; Jerod Rasmussen; Jessica Turner; Vince D Calhoun; Sarah Young; Bryon Mueller; Gregory G Brown; Gregory McCarthy; Gary H Glover; Kelvin O Lim; Juan R Bustillo; Aysenil Belger; Sarah McEwen; James Voyvodic; Daniel H Mathalon; David Keator; Adrian Preda; Dana Nguyen; Judith M Ford; Steven G Potkin
Journal:  Psychiatry Res       Date:  2014-02-28       Impact factor: 3.222

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.